Fed’s Kaplan: Market’s odds for rate hike between now and June ‘in neighborhood of where we’re heading’

WASHINGTON (MarketWatch) – The financial market is pricing in the probability of an interest-rate hike by the U.S. central bank in either March, May or June and that is “likely in the neighborhood of where we are heading,” said Dallas Fed President Rob Kaplan on Tuesday. “What market probabilities probably suggest is between now and June – in either the March, May or June meeting – you are going to see some action,” Kaplan said in an interview on CNBC. “I don’t think the exact timing is the most important thing. I think the path of rates is,” he said. The CME Group’s Fed funds futures pricing shows that traders see a 31% chance for a quarter-point rate hike in March. They bump those odds up to 54% for May and 73% for June. Kaplan, who is a rate-policy voter this year, said the economy is making good progress toward the Fed’s goals of full employment and a stable 2% rate of inflation. He said growth should be above 2% this year even before fiscal policies that could provide some upside. Given this outlook, “we should be taking steps to remove some amount of accommodation sooner rather than later,” he said.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Kite Pharma reports positive results from non-Hodgkins lymphoma drug study

Kite Pharma Inc. said Tuesday a study of a treatment for aggressive non-Hodgkin lymphoma met its main goal in a trial. The company said the first analysis of data for its lead CAR-T candidate, axicabtagene ciloleucel (previously referred to as KTE-C19), in patients with chemorefractory aggressive B-cell non-Hodgkin lymphoma met its primary endpoint. The study involved 101 patients, 41% of whom had recorded a response at month six. “Five of the 101 patients (5 percent) continue to experience highly significant and durable partial responses (PR) with minimal abnormalities in PET scans,” the company said in a statement. The results “are exceptional and suggest that more than a third of patients with refractory aggressive NHL could potentially be cured after a single infusion of axicabtagene ciloleucel, ” said Jeff Wiezorek, M.D., senior vice president of clinical development. The company will present the data at the American Association for Cancer Research in April 2017 in Washington, D.C. Shares were halted for the news.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Domino’s Pizza reports earnings beat, raises dividend

Domino’s Pizza Inc. reported fourth-quarter net income of $72.7 million, or $1.48 per share, up from $62.8 million, or $1.18 per share. The FactSet consensus was $1.44. Sales were $819.4 million, up from $741.2 million and ahead of the $782.0 million FactSet consensus. Domestic same-store sales rose 12.2% for the quarter, and same-store sales for the international division was up 4.3%. Domino’s raised its dividend 21.1% to 46 cents per share for shareholders of record as of March 15, 2017 to be paid on March 30, 2017. Domino’s shares are unchanged in Tuesday premarket trading, and up 38% for the past year. The S&P 500 index is up 21.7% for the last 12 months.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Amazon offering restaurant delivery service in D.C.

Amazon.com Inc. said Tuesday that it has launched restaurant delivery service in Washington D.C. for Prime members. Customers in the greater D.C. area, including Northern Virginia, Georgetown and other neighborhoods, can have orders from 150 restaurants delivered. Food is delivered in one hour or less. Amazon shares are up 0.3% in premarket trading, and up nearly 53% for the past year. The S&P 500 index is up 21.7% for the last 12 months.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Target’s stock set to suffer biggest price decline since it went public 45 years ago

Target Corp.’s stock plunged 14% in active premarket trade Tuesday, in the wake of a disappointing fiscal fourth-quarter report, putting it on track to open at a 2 1/2-year low. Current volume of about 276,000 shares made the stock the most actively traded before the open. The stock’s $9.41, or 14.1%, drop to $57.50 ahead of the open would put it on track to open at the lowest level seen since Aug. 7, 2014. The stock would suffer the biggest one-day price drop since it went public in January 1972, and the third-biggest-ever percentage decline, and the biggest since Aug. 31, 1998. Earlier,Target missed fiscal fourth-quarter profit expectations, and provided first-quarter and full-year outlooks that were well below analyst projections. The stock has tumbled 15% over the past 12 months, while the SPDR S&P Retail ETF has gained 1.6% and the S&P 500 has climbed 22%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Valeant posts wider loss for fourth quarter as revenue dips

Valeant Pharmaceuticals International Inc. shares jumped, then reversed their gains, in premarket trade Tuesday, after the company reported a fourth-quarter loss and decline in revenues, but still beat Wall Street estimates. Valeant, which was immersed in an accounting and drug pricing scandal last year, said it had a net loss of $512 million, or $1.47 a share, in the quarter, after a loss of $385 million, or $1.12 a share, in the year-earlier period. Excluding special items, the company had adjusted EPS of $1.26, ahead of the FactSet consensus of $1.20. Revenue fell to $2.4 billion from $2.7 billion, but were also ahead of the FactSet consensus of $2.3 billion. Joseph Papa, the CEO who was brought in to turn the company around, said it had improved its position in 2016. “We paid all 2017 amortizations and reduced debt by $519 million in the fourth quarter,” Papa said in a statement. “We agreed to divest a number of assets, including several skincare brands, our Dendreon business and smaller international interests. The U.S. Food and Drug Administration (FDA) approved our new psoriasis treatment, SILIQ(TM), and we resubmitted our glaucoma treatment, latanoprostene bunod in February 2017.” The company is expecting 2017 revenue to range from $8.9 billion to $9.1 billion. Shares are down 79% in the last 12 months, while the S&P 500 has gained 22%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Starbucks to open cafes and a Roastery in Milan in 2018

Starbucks Corp. said Tuesday that the first of its Starbucks Roastery locations in the Europe, Middle East and Africa regions will open in Milan in 2018. It will be the fifth location in the world. The Starbucks Roastery is a large retail space where rare coffees are roasted and tasted. The Milan Roastery will be in a 25,500-square-foot former post office on Piazza Cordusio. In time, Starbucks plans to open 20 to 30 Roastery locations around the world. Along with its business partner Percassi, Starbucks will also open a number of smaller cafes in Milan in 2018, hiring 350 employees in Italy. A Starbucks Roastery is heading to Shanghai in 2017 and New York and Tokyo in 2018. Starbucks shares are nearly flat in premarket trading, and down 2.7% for the past year. The S&P 500 index is up 21.7% for the last 12 months.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Wilbur Ross confirmed to lead Commerce Department

The U.S. Senate confirmed Wilbur Ross as secretary of commerce Monday evening by a 72-27 vote. Ross, 79, a billionaire investor, is expected to play a crucial role in President Donald Trump’s plans to change U.S. trade policy, including renegotiating the North American Free Trade Agreement.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Kindred Healthcare tp halt dividend after March to pay debt, invest in growth

Shares of Kindred Healthcare Inc. rose more than 4% late Monday after the company said it will halt its dividend after a March dividend payment in order to pay down debt and invest in growth. Kindred said in a statement its board of directors approved a cash dividend of 12 cents a share, payable March 31 to shareholders of record March 13, and has determined that the company’s stock trading levels “do not sufficiently reflect the value of the company’s quarterly cash dividend.” Shares of Kindred ended the regular trading session up 3.3%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Elon Musk’s SpaceX to fly two people to the moon in 2018

Privately held SpaceX said late Monday it has been approached to fly two “private citizens” on a trip around the moon late next year. The two people have already paid a “significant deposit” to do a moon mission, the company, led by Tesla Inc. CEO Elon Musk, said in a statement. “Like the Apollo astronauts before them, these individuals will travel into space carrying the hopes and dreams of all humankind, driven by the universal human spirit of exploration,” SpaceX said. Health and fitness tests as well as training will begin late this year, the company said. “Other flight teams have also expressed strong interest and we expect more to follow. Additional information will be released about the flight teams, contingent upon their approval and confirmation of the health and fitness test results,” the company said.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News